Source: International Congress 2015 – Inflammation and remodelling in lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nikolaos Soulitzis (Heraklion, Crete, Greece), Nikolaos Soulitzis, Eirini Neofytou, Nikoletta Rovina, Eleftherios Zervas, Dimitra Papandrinopoulou, Nikolaos Siafakas. Cytotoxic activity and oxidative DNA damage in smoking asthmatics versus COPD patients. Eur Respir J 2015; 46: Suppl. 59, 3923

Member's Comments

No comment yet.

Related content which might interest you: Granule cytotoxic activity and oxidative DNA damage in smoking and non-smoking asthmatics Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 The effect of smoking on the activity of inflammatory markers in patients with COPD Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Higher burden of asthma symptoms and increased blood eosinophils in ACOS Source: International Congress 2016 – Systemic biomarkers Year: 2016 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Cytokine patterns and latent viruses in patients with severe asthma and COPD Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Comparing the effects of oxidative stress on mitochondrial function and antiviral responses in primary bronchial epithelial cells of asthmatics and non-asthmatics Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Evaluation of vitamin D levels in COPD and its correlation with disease severity and frequency of exacerbations Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Various biomarkers of oxidative stress in patients with uncontrolled asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Malanoyl dialdehyde (MDA) and hs-CRP: How are they linked to COPD? Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Oxidative stress and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Autoreactivity in patients with combined COPD and asthma phenotype Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 MUC1-CT mediates corticosteroid responses in COPD Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016